FDA Panel Calls for Restrictions on Johnson & Johnson (Jobs) and Amgen (Jobs) Anemia Drugs

May 11, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

SILVER SPRING, Md., May 10 (Reuters) - A U.S. advisory panel on Thursday called for marketing restrictions on popular anemia drugs sold by Amgen Inc. (AMGN.O: Quote, Profile , Research) and Johnson & Johnson(JNJ.N: Quote, Profile , Research).

>>> Discuss This Story

Twitter
LinkedIn
Facebook
Email
Print

Amgen Johnson & Johnson Family of Companies Food and Drug Administration (FDA)